4EYM | MAPK13 complex with inhibitor | date | 2012-05-01 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Miller, C.A., Brett, T.J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.35 | ||||||||||||
ligand | 0RX | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | IL-13-induced airway mucus production is attenuated by MAPK13 inhibition., Alevy YG, Patel AC, Romero AG, Patel DA, Tucker J, Roswit WT, Miller CA, Heier RF, Byers DE, Brett TJ, Holtzman MJ, J Clin Invest. 2012 Dec 3;122(12):4555-68. doi: 10.1172/JCI64896. Epub 2012 Nov, 26. PMID:23187130 |
Data retrieval |
View 4EYM in 3D |
Visual 3D analysis of 4EYM |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4EYM |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |